Abbott Reports First-Quarter 2022 Results

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2022....

Related Keywords

China ,Japan ,Robertb Ford , ,Linkedin ,Drug Administration ,Core Laboratory Diagnostics ,Sales In Core Laboratory ,European Union Medical Device ,Facebook ,Abbott Laboratories ,Core Laboratory ,Medical Devices ,Established Pharmaceuticals ,Adult Nutrition ,Pediatric Nutrition ,Molecular Diagnostics ,Emerging Markets ,Heart Failure ,Structural Heart ,Diabetes Care ,Freestyle Libre ,Aristocrats Index ,Investor Relations ,Private Securities Litigation Reform Act ,Caution Concerning Forward Looking ,Annual Report ,Consolidated Statement ,Quarter Ended March ,Operating Cost ,Earnings Excluding Specified Items ,Common Share ,Specified Items ,Common Shares ,Dilutive Common Stock Options ,Diluted Earnings ,Financial Information ,Gross Margin ,European Union ,Medical Device ,Vitro Diagnostics Medical Device ,Abbott ,